Woodcliff Lake-based Par announced that its partner companies — Mumbai, India-based Glenmark Generics Ltd. and Mahwah-based Glenmark Generics Inc. USA — entered into a settlement agreement that resolves a Glenmark lawsuit challenging Merck's patent of Zetia, a cholesterol drug that accounts for an estimated $1.4 billion of sales per year in the United States.